ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SLP Simulations Plus Inc

47.19
0.47 (1.01%)
Last Updated: 18:43:21
Delayed by 15 minutes
Share Name Share Symbol Market Type
Simulations Plus Inc NASDAQ:SLP NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.47 1.01% 47.19 47.09 47.19 47.46 46.915 47.00 18,125 18:43:21

Simulations Plus Sets Date for 3rd Quarter 2019 Earnings Release and Conference Call

02/07/2019 1:30pm

Business Wire


Simulations Plus (NASDAQ:SLP)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Simulations Plus Charts.

Conference Call to be on Wednesday, July 10, 2019, at 4:15 PM ET

Simulations Plus, Inc. (Nasdaq: SLP) announced today that it will report its third quarter financial results for fiscal year 2019, the period ended May 31, 2019, after the close of the financial markets on Wednesday, July 10. 2019.

The Company will host a conference call on July 10, 2019, at 4:15 p.m. Eastern Time. All interested parties are invited to join the call by registering here. On registering, you will receive a confirmation e-mail with instructions for joining the call. Please dial in five to ten minutes prior to the scheduled start time. A live, listen-only teleconference will be available by dialing (914) 614-3221, and entering access code 952-038-001. A replay of the webcast will be available at the Investors section of the Simulations Plus website following the call.

About Simulations Plus, Inc.

Simulations Plus, Inc., is the premier developer of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen Corporation and DILIsym Services, we offer #1-ranked, easy-to-use software to bridge data mining and compound library screening with QSAR models, PBPK/TK modeling and simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. Our technology is now licensed and used by major pharmaceutical and biotechnology companies and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com.

Follow us on Twitter | LinkedIn

Simulations Plus Investor Relations Ms. Renee Bouche 661-723-7723 renee@simulations-plus.com

Hayden IR Mr. Cameron Donahue 651-653-1854 cameron@haydenir.com

1 Year Simulations Plus Chart

1 Year Simulations Plus Chart

1 Month Simulations Plus Chart

1 Month Simulations Plus Chart

Your Recent History

Delayed Upgrade Clock